Accueil

Tasimelteon

Tasimelteon

Spécifications

609799-22-6Numéro CAS
612-059-5Numéro CE
N-[[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl]propanamideNom IUPAC
C15H19NO2Formule chimique
245.32 g/molMasse molaire
Tasimelteon; 609799-22-6; Hetlioz; VEC-162; BMS-214778; VEC 162; HETLIOZ LQ; tasimelteonum; BMS 214778; BMS-214,778; SHS4PU80D9; BMS214778; CHEBI:79042; N-{[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl}propanamide; DTXSID70209826; N-[[(1R,2R)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl]propanamide; N-((2-(2,3-dihydro-4-benzofuranyl)cyclopropyl)methyl)propanamide; N-(((1R,2R)-2-(2,3-Dihydro-1-benzofuran-4-yl)cyclopropyl)methyl)propanamide; N-([(1r,2r)-2-(2,3-dihydro-1-benzofuran-4-yl)cyclopropyl]methyl)propanamide; RefChem:57589; DTXCID20132317; N05CH03; N-(((1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl)methyl)propionamide; MFCD09033789; Propanamide, N-(((1R,2R)-2-(2,3-dihydro-4-benzofuranyl)cyclopropyl)methyl)-; Tasimelteon [USAN]; Tasimelteon Impurity 1; Tasimelteon [USAN:INN]; UNII-SHS4PU80D9; BMS-214778;VEC-162; Hetlioz (TN); Tasimelteon (Standard); TASIMELTEON [MI]; TASIMELTEON [INN]; Tasimelteon (USAN/INN); TASIMELTEON [VANDF]; TASIMELTEON [MART.]; TASIMELTEON [WHO-DD]; GTPL7393; orb1223090; orb1304147; SCHEMBL3505912; CHEMBL2103822; SCHEMBL29351713; Tasimelteon, >=98% (HPLC); TASIMELTEON [ORANGE BOOK]; GLXC-07665; HMS3885L17; EX-A2729; BDBM50621041; EBC-26299; HY-14803R; s4281; AKOS025149360; N-[[(1R,2R)-2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl]methyl]propanamide; AC-6143; CCG-266915; CS-5512; DB09071; NCGC00522560-01; NCGC00522560-02; AS-35291; HY-14803; NS00034514; D09388; EN300-20605494; F807195; Q7687250; BRD-K62971431-001-01-9; (trans)-N-[[2-(2,3-dihydrobenzofuran-4-yl) cyclopropyl]methyl]propanamide; (trans)-N-[[2-(2,3-dihydrobenzofuran-4-yl)cyclopropyl]methyl]propanamide; (-)-(trans)-N-[[2-(2,3-Dihydrobenzofuran-4-yl)cycloprop-1-yl] methyl]propanamideSynonymes